nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefenamic acid—PTGS2—amyotrophic lateral sclerosis	0.668	1	CbGaD
Mefenamic acid—Haematemesis—Riluzole—amyotrophic lateral sclerosis	0.00634	0.0285	CcSEcCtD
Mefenamic acid—Pulmonary function test decreased—Riluzole—amyotrophic lateral sclerosis	0.00585	0.0263	CcSEcCtD
Mefenamic acid—Respiratory depression—Riluzole—amyotrophic lateral sclerosis	0.00585	0.0263	CcSEcCtD
Mefenamic acid—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.00478	0.0215	CcSEcCtD
Mefenamic acid—Ulcer—Riluzole—amyotrophic lateral sclerosis	0.00466	0.021	CcSEcCtD
Mefenamic acid—Melaena—Riluzole—amyotrophic lateral sclerosis	0.0043	0.0194	CcSEcCtD
Mefenamic acid—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.00418	0.0188	CcSEcCtD
Mefenamic acid—Aplastic anaemia—Riluzole—amyotrophic lateral sclerosis	0.00413	0.0186	CcSEcCtD
Mefenamic acid—Coma—Riluzole—amyotrophic lateral sclerosis	0.00402	0.0181	CcSEcCtD
Mefenamic acid—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.00398	0.0179	CcSEcCtD
Mefenamic acid—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.00382	0.0172	CcSEcCtD
Mefenamic acid—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.00375	0.0169	CcSEcCtD
Mefenamic acid—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.00375	0.0169	CcSEcCtD
Mefenamic acid—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.00364	0.0164	CcSEcCtD
Mefenamic acid—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00357	0.0161	CcSEcCtD
Mefenamic acid—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00357	0.0161	CcSEcCtD
Mefenamic acid—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.00353	0.0159	CcSEcCtD
Mefenamic acid—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.00339	0.0153	CcSEcCtD
Mefenamic acid—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00332	0.0149	CcSEcCtD
Mefenamic acid—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.0033	0.0149	CcSEcCtD
Mefenamic acid—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.00321	0.0145	CcSEcCtD
Mefenamic acid—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0032	0.0144	CcSEcCtD
Mefenamic acid—Niflumic Acid—PLA2G4A—amyotrophic lateral sclerosis	0.00297	0.248	CrCbGaD
Mefenamic acid—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00295	0.0133	CcSEcCtD
Mefenamic acid—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00283	0.0127	CcSEcCtD
Mefenamic acid—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00276	0.0124	CcSEcCtD
Mefenamic acid—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00271	0.0122	CcSEcCtD
Mefenamic acid—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00262	0.0118	CcSEcCtD
Mefenamic acid—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00258	0.0116	CcSEcCtD
Mefenamic acid—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00252	0.0114	CcSEcCtD
Mefenamic acid—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00248	0.0112	CcSEcCtD
Mefenamic acid—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00243	0.0109	CcSEcCtD
Mefenamic acid—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00241	0.0109	CcSEcCtD
Mefenamic acid—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.0024	0.0108	CcSEcCtD
Mefenamic acid—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.0024	0.0108	CcSEcCtD
Mefenamic acid—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00235	0.0106	CcSEcCtD
Mefenamic acid—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.0023	0.0104	CcSEcCtD
Mefenamic acid—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00222	0.01	CcSEcCtD
Mefenamic acid—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00221	0.00996	CcSEcCtD
Mefenamic acid—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00221	0.00996	CcSEcCtD
Mefenamic acid—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.0022	0.00991	CcSEcCtD
Mefenamic acid—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00218	0.00983	CcSEcCtD
Mefenamic acid—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00217	0.00976	CcSEcCtD
Mefenamic acid—Acetylsalicylic acid—TP53—amyotrophic lateral sclerosis	0.00209	0.175	CrCbGaD
Mefenamic acid—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00209	0.00942	CcSEcCtD
Mefenamic acid—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00198	0.0089	CcSEcCtD
Mefenamic acid—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00195	0.0088	CcSEcCtD
Mefenamic acid—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00194	0.00872	CcSEcCtD
Mefenamic acid—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.0019	0.00854	CcSEcCtD
Mefenamic acid—Tension—Riluzole—amyotrophic lateral sclerosis	0.00189	0.00851	CcSEcCtD
Mefenamic acid—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00187	0.00842	CcSEcCtD
Mefenamic acid—Tremor—Riluzole—amyotrophic lateral sclerosis	0.0018	0.00812	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00804	CcSEcCtD
Mefenamic acid—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00178	0.00801	CcSEcCtD
Mefenamic acid—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00176	0.00792	CcSEcCtD
Mefenamic acid—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00174	0.00782	CcSEcCtD
Mefenamic acid—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00173	0.00779	CcSEcCtD
Mefenamic acid—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00173	0.00777	CcSEcCtD
Mefenamic acid—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00172	0.00776	CcSEcCtD
Mefenamic acid—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.0017	0.00766	CcSEcCtD
Mefenamic acid—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00169	0.00762	CcSEcCtD
Mefenamic acid—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00167	0.00751	CcSEcCtD
Mefenamic acid—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00166	0.00748	CcSEcCtD
Mefenamic acid—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00735	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00733	CcSEcCtD
Mefenamic acid—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00162	0.00729	CcSEcCtD
Mefenamic acid—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.0016	0.00722	CcSEcCtD
Mefenamic acid—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00158	0.00713	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00157	0.00707	CcSEcCtD
Mefenamic acid—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00157	0.00707	CcSEcCtD
Mefenamic acid—Infection—Riluzole—amyotrophic lateral sclerosis	0.00156	0.00703	CcSEcCtD
Mefenamic acid—Shock—Riluzole—amyotrophic lateral sclerosis	0.00155	0.00696	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00154	0.00693	CcSEcCtD
Mefenamic acid—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00153	0.00691	CcSEcCtD
Mefenamic acid—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00153	0.00687	CcSEcCtD
Mefenamic acid—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.0015	0.00674	CcSEcCtD
Mefenamic acid—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00147	0.00661	CcSEcCtD
Mefenamic acid—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00142	0.0064	CcSEcCtD
Mefenamic acid—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00141	0.00635	CcSEcCtD
Mefenamic acid—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.0014	0.00631	CcSEcCtD
Mefenamic acid—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.0014	0.00629	CcSEcCtD
Mefenamic acid—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00138	0.00623	CcSEcCtD
Mefenamic acid—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00615	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00136	0.00611	CcSEcCtD
Mefenamic acid—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00134	0.00605	CcSEcCtD
Mefenamic acid—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00583	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00128	0.00579	CcSEcCtD
Mefenamic acid—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00125	0.00562	CcSEcCtD
Mefenamic acid—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00559	CcSEcCtD
Mefenamic acid—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00559	CcSEcCtD
Mefenamic acid—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00113	0.00508	CcSEcCtD
Mefenamic acid—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00501	CcSEcCtD
Mefenamic acid—Floctafenine—PTGS2—amyotrophic lateral sclerosis	0.00108	0.09	CrCbGaD
Mefenamic acid—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00108	0.00484	CcSEcCtD
Mefenamic acid—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00468	CcSEcCtD
Mefenamic acid—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000999	0.0045	CcSEcCtD
Mefenamic acid—Rash—Riluzole—amyotrophic lateral sclerosis	0.000991	0.00446	CcSEcCtD
Mefenamic acid—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00099	0.00446	CcSEcCtD
Mefenamic acid—Headache—Riluzole—amyotrophic lateral sclerosis	0.000984	0.00443	CcSEcCtD
Mefenamic acid—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000933	0.0042	CcSEcCtD
Mefenamic acid—Lumiracoxib—PTGS2—amyotrophic lateral sclerosis	0.000694	0.058	CrCbGaD
Mefenamic acid—Tiaprofenic acid—PTGS2—amyotrophic lateral sclerosis	0.000694	0.058	CrCbGaD
Mefenamic acid—Nepafenac—PTGS2—amyotrophic lateral sclerosis	0.00066	0.0552	CrCbGaD
Mefenamic acid—Niflumic Acid—PTGS2—amyotrophic lateral sclerosis	0.000618	0.0517	CrCbGaD
Mefenamic acid—AKR1C1—Disease—TPK1—amyotrophic lateral sclerosis	0.000616	0.0063	CbGpPWpGaD
Mefenamic acid—PTGS2—Selenium Micronutrient Network—GSR—amyotrophic lateral sclerosis	0.000606	0.0062	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000597	0.00611	CbGpPWpGaD
Mefenamic acid—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—amyotrophic lateral sclerosis	0.000597	0.00611	CbGpPWpGaD
Mefenamic acid—PTGS1—Overview of nanoparticle effects—PTGS2—amyotrophic lateral sclerosis	0.000595	0.00609	CbGpPWpGaD
Mefenamic acid—PTGS2—Prostaglandin Synthesis and Regulation—PLA2G4A—amyotrophic lateral sclerosis	0.000581	0.00595	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000562	0.00575	CbGpPWpGaD
Mefenamic acid—AKR1C3—Diseases associated with visual transduction—APOE—amyotrophic lateral sclerosis	0.00055	0.00563	CbGpPWpGaD
Mefenamic acid—Salsalate—PTGS2—amyotrophic lateral sclerosis	0.000548	0.0459	CrCbGaD
Mefenamic acid—Meclofenamic acid—PTGS2—amyotrophic lateral sclerosis	0.00054	0.0452	CrCbGaD
Mefenamic acid—AKR1C1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000516	0.00528	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000516	0.00528	CbGpPWpGaD
Mefenamic acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—PLA2G4A—amyotrophic lateral sclerosis	0.000514	0.00526	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—DAO—amyotrophic lateral sclerosis	0.000508	0.0052	CbGpPWpGaD
Mefenamic acid—PTGS1—Eicosanoid Synthesis—PTGS2—amyotrophic lateral sclerosis	0.000494	0.00505	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—VTA1—amyotrophic lateral sclerosis	0.000492	0.00504	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—RTN4—amyotrophic lateral sclerosis	0.000488	0.005	CbGpPWpGaD
Mefenamic acid—PTGS1—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000487	0.00498	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000481	0.00492	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000472	0.00483	CbGpPWpGaD
Mefenamic acid—Fenoprofen—PTGS2—amyotrophic lateral sclerosis	0.000453	0.0379	CrCbGaD
Mefenamic acid—AKR1C3—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000447	0.00457	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000438	0.00449	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000427	0.00437	CbGpPWpGaD
Mefenamic acid—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—amyotrophic lateral sclerosis	0.000427	0.00437	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.000415	0.00425	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—TPK1—amyotrophic lateral sclerosis	0.000414	0.00424	CbGpPWpGaD
Mefenamic acid—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—amyotrophic lateral sclerosis	0.000413	0.00422	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000412	0.00422	CbGpPWpGaD
Mefenamic acid—Acetylsalicylic acid—PTGS2—amyotrophic lateral sclerosis	0.00041	0.0343	CrCbGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—GFAP—amyotrophic lateral sclerosis	0.000398	0.00407	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—AQP4—amyotrophic lateral sclerosis	0.000394	0.00403	CbGpPWpGaD
Mefenamic acid—PTGS2—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000386	0.00395	CbGpPWpGaD
Mefenamic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—amyotrophic lateral sclerosis	0.000386	0.00395	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000385	0.00394	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—CHMP2B—amyotrophic lateral sclerosis	0.000373	0.00382	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000373	0.00381	CbGpPWpGaD
Mefenamic acid—PTGS2—S1P1 pathway—VEGFA—amyotrophic lateral sclerosis	0.000372	0.00381	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—GSR—amyotrophic lateral sclerosis	0.000355	0.00364	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000347	0.00355	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000347	0.00355	CbGpPWpGaD
Mefenamic acid—PTGS1—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.000345	0.00353	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000339	0.00347	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.000339	0.00347	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—PLB1—amyotrophic lateral sclerosis	0.000337	0.00345	CbGpPWpGaD
Mefenamic acid—Salicylic acid—PTGS2—amyotrophic lateral sclerosis	0.000337	0.0282	CrCbGaD
Mefenamic acid—AKR1C3—Disease—VTA1—amyotrophic lateral sclerosis	0.000331	0.00339	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000324	0.00331	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000324	0.00331	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000317	0.00325	CbGpPWpGaD
Mefenamic acid—CYP2C8—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000314	0.00322	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00031	0.00317	CbGpPWpGaD
Mefenamic acid—Diclofenac—PTGS2—amyotrophic lateral sclerosis	0.000302	0.0253	CrCbGaD
Mefenamic acid—AKR1C1—Disease—VCP—amyotrophic lateral sclerosis	0.000301	0.00308	CbGpPWpGaD
Mefenamic acid—Flurbiprofen—PTGS2—amyotrophic lateral sclerosis	0.000296	0.0247	CrCbGaD
Mefenamic acid—AKR1C3—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000295	0.00302	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000292	0.00299	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000288	0.00295	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000285	0.00291	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000283	0.00289	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000277	0.00284	CbGpPWpGaD
Mefenamic acid—PTGS1—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000274	0.00281	CbGpPWpGaD
Mefenamic acid—PTGS2—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.000274	0.0028	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000271	0.00277	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000269	0.00275	CbGpPWpGaD
Mefenamic acid—Ketoprofen—PTGS2—amyotrophic lateral sclerosis	0.000267	0.0224	CrCbGaD
Mefenamic acid—AKR1C2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000266	0.00272	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000261	0.00267	CbGpPWpGaD
Mefenamic acid—CYP2C9—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000256	0.00262	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—CHMP2B—amyotrophic lateral sclerosis	0.000251	0.00257	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—DAO—amyotrophic lateral sclerosis	0.000251	0.00257	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000246	0.00252	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000237	0.00243	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000236	0.00242	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000233	0.00238	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000232	0.00237	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000229	0.00234	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—PLB1—amyotrophic lateral sclerosis	0.000227	0.00232	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000226	0.00231	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000222	0.00227	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000219	0.00224	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—CST3—amyotrophic lateral sclerosis	0.000216	0.00221	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000215	0.0022	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000214	0.00219	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000213	0.00218	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000211	0.00215	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000204	0.00209	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—BDNF—amyotrophic lateral sclerosis	0.000204	0.00208	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—VCP—amyotrophic lateral sclerosis	0.000202	0.00207	CbGpPWpGaD
Mefenamic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—amyotrophic lateral sclerosis	0.000202	0.00207	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.0002	0.00205	CbGpPWpGaD
Mefenamic acid—PTGS1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000197	0.00202	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000195	0.002	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00019	0.00195	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000186	0.00191	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000186	0.0019	CbGpPWpGaD
Mefenamic acid—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	0.000183	0.00188	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000182	0.00187	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000181	0.00185	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000179	0.00183	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000178	0.00182	CbGpPWpGaD
Mefenamic acid—CYP2C8—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000177	0.00181	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—GSR—amyotrophic lateral sclerosis	0.000175	0.0018	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000175	0.00179	CbGpPWpGaD
Mefenamic acid—PTGS1—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.000175	0.00179	CbGpPWpGaD
Mefenamic acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—amyotrophic lateral sclerosis	0.000172	0.00176	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000164	0.00168	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000163	0.00167	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.00016	0.00164	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000159	0.00163	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—CASP9—amyotrophic lateral sclerosis	0.000157	0.00161	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000157	0.0016	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000152	0.00155	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000151	0.00155	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000151	0.00155	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000149	0.00153	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000148	0.00151	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—CST3—amyotrophic lateral sclerosis	0.000145	0.00149	CbGpPWpGaD
Mefenamic acid—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000144	0.00148	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000144	0.00147	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000144	0.00147	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—TPK1—amyotrophic lateral sclerosis	0.000143	0.00146	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000143	0.00146	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000142	0.00145	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000141	0.00144	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000139	0.00142	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000138	0.00141	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000137	0.0014	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—ERBB4—amyotrophic lateral sclerosis	0.000134	0.00137	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000134	0.00137	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000132	0.00135	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000131	0.00135	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000128	0.00131	CbGpPWpGaD
Mefenamic acid—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000127	0.0013	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000126	0.00128	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000123	0.00126	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000122	0.00125	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000121	0.00124	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.00012	0.00123	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00012	0.00123	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00012	0.00123	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00012	0.00123	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—APOE—amyotrophic lateral sclerosis	0.000119	0.00121	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000115	0.00118	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000115	0.00118	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—VTA1—amyotrophic lateral sclerosis	0.000114	0.00117	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000112	0.00114	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.00011	0.00112	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00011	0.00112	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000109	0.00112	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000106	0.00108	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—CASP9—amyotrophic lateral sclerosis	0.000106	0.00108	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—APOE—amyotrophic lateral sclerosis	0.000104	0.00106	CbGpPWpGaD
Mefenamic acid—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000104	0.00106	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000102	0.00105	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000102	0.00104	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—CASP3—amyotrophic lateral sclerosis	0.000102	0.00104	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	9.77e-05	0.001	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	9.76e-05	0.000998	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	9.76e-05	0.000998	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—MMP9—amyotrophic lateral sclerosis	9.61e-05	0.000984	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—FIG4—amyotrophic lateral sclerosis	9.59e-05	0.000981	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	9.41e-05	0.000962	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	9.1e-05	0.000931	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—ERBB4—amyotrophic lateral sclerosis	9.04e-05	0.000925	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	9.01e-05	0.000922	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	8.99e-05	0.00092	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	8.92e-05	0.000913	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	8.84e-05	0.000905	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—APOE—amyotrophic lateral sclerosis	8.7e-05	0.00089	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CHMP2B—amyotrophic lateral sclerosis	8.67e-05	0.000888	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—DAO—amyotrophic lateral sclerosis	8.67e-05	0.000887	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.3e-05	0.000849	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	8.28e-05	0.000847	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PLB1—amyotrophic lateral sclerosis	8.28e-05	0.000847	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.12e-05	0.000831	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	7.94e-05	0.000812	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	7.94e-05	0.000812	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PLB1—amyotrophic lateral sclerosis	7.84e-05	0.000803	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.82e-05	0.0008	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	7.8e-05	0.000798	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	7.76e-05	0.000794	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.74e-05	0.000792	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—GSR—amyotrophic lateral sclerosis	7.64e-05	0.000781	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	7.4e-05	0.000758	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	7.39e-05	0.000757	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.28e-05	0.000744	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	7.26e-05	0.000743	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—PTGS2—amyotrophic lateral sclerosis	7.12e-05	0.000728	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.12e-05	0.000728	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	7.05e-05	0.000722	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—VCP—amyotrophic lateral sclerosis	6.99e-05	0.000715	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—APOE—amyotrophic lateral sclerosis	6.99e-05	0.000715	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	6.96e-05	0.000712	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	6.92e-05	0.000708	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.75e-05	0.000691	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PLB1—amyotrophic lateral sclerosis	6.57e-05	0.000672	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	6.52e-05	0.000667	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	6.35e-05	0.00065	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	6.33e-05	0.000648	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CHAT—amyotrophic lateral sclerosis	6.27e-05	0.000642	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—GSR—amyotrophic lateral sclerosis	6.06e-05	0.00062	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.01e-05	0.000615	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.96e-05	0.00061	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	5.95e-05	0.000609	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	5.87e-05	0.000601	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—APOE—amyotrophic lateral sclerosis	5.86e-05	0.000599	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	5.74e-05	0.000587	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	5.72e-05	0.000586	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	5.52e-05	0.000565	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	5.35e-05	0.000547	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.26e-05	0.000538	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CST3—amyotrophic lateral sclerosis	5.02e-05	0.000513	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CHAT—amyotrophic lateral sclerosis	4.98e-05	0.000509	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	4.93e-05	0.000505	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.9e-05	0.000501	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—PTGS2—amyotrophic lateral sclerosis	4.79e-05	0.00049	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.63e-05	0.000474	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.54e-05	0.000465	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.49e-05	0.00046	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	4.44e-05	0.000454	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.37e-05	0.000447	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	4.35e-05	0.000445	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	4.05e-05	0.000415	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.05e-05	0.000414	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	4.01e-05	0.000411	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.01e-05	0.000411	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.93e-05	0.000402	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.92e-05	0.000401	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.7e-05	0.000378	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.66e-05	0.000374	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CASP9—amyotrophic lateral sclerosis	3.65e-05	0.000373	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.37e-05	0.000345	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	3.3e-05	0.000337	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—ERBB4—amyotrophic lateral sclerosis	3.12e-05	0.00032	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.11e-05	0.000319	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.1e-05	0.000317	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.01e-05	0.000308	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.97e-05	0.000304	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.94e-05	0.000301	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.68e-05	0.000274	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.64e-05	0.00027	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—APOE—amyotrophic lateral sclerosis	2.55e-05	0.000261	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.53e-05	0.000259	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.46e-05	0.000252	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—APOE—amyotrophic lateral sclerosis	2.42e-05	0.000247	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.18e-05	0.000223	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.06e-05	0.000211	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—APOE—amyotrophic lateral sclerosis	2.02e-05	0.000207	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2e-05	0.000205	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2e-05	0.000204	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.77e-05	0.000181	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.75e-05	0.000179	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	1.65e-05	0.000168	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.63e-05	0.000167	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	1.34e-05	0.000137	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.13e-05	0.000115	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.18e-06	9.39e-05	CbGpPWpGaD
